• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

可溶性 Klotho 水平与维持性血液透析患者不良结局的关联。

Association of Soluble Klotho Level with Adverse Outcomes in Patients on Maintenance Hemodialysis.

机构信息

Department of Nephrology, Affiliated Kunshan Hospital of Jiangsu University, 91 Qianjin West Road, Kunshan, Jiangsu 215300, China.

Clinical Research & Lab Centre, Affiliated Kunshan Hospital of Jiangsu University, 91 Qianjin West Road, Kunshan, Jiangsu 215300, China.

出版信息

Dis Markers. 2020 Nov 12;2020:4923970. doi: 10.1155/2020/4923970. eCollection 2020.

DOI:10.1155/2020/4923970
PMID:33299496
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7708020/
Abstract

BACKGROUND

The predictive value of soluble Klotho (sKlotho) for adverse outcomes in patients on maintenance hemodialysis (MHD) is controversial. In this study, we aimed to clarify the potential association of sKlotho levels with adverse outcomes in this patient population.

MATERIALS

A total of 211 patients on MHD were identified and stratified according to the median sKlotho level. Patients were followed up for adverse outcomes including cardiovascular (CV) morbidity and all-cause mortality.

RESULTS

During the 36-month follow-up, 75 patients [51 CV events (including 16 CV deaths) and 40 deaths] experienced adverse outcomes. After stratification according to median sKlotho level, patients with a lower sKlotho level had a greater risk of CV events (38.2% vs. 19.5%, = 0.006), all-cause mortality (28.4% vs. 11.6%, = 0.003), and combined adverse outcomes (51.0% vs. 24.2%, < 0.001). Similar observations were made from analyses using Kaplan-Meier survival curves. Cox regression analysis showed that a low sKlotho level was strongly correlated with CV morbidity [1.942 (1.030-3.661), = 0.040)], all-cause mortality [2.073 (1.023-4.203), = 0.043], and combined adverse outcomes [1.818 (1.092-3.026), = 0.021] in fully adjusted models.

CONCLUSIONS

The sKlotho level was an independent predictive factor of adverse outcomes including CV morbidity and mortality in patients on MHD.

摘要

背景

可溶性 Klotho(sKlotho)对维持性血液透析(MHD)患者不良结局的预测价值存在争议。本研究旨在明确 sKlotho 水平与该患者人群不良结局的潜在关联。

材料

共纳入 211 名 MHD 患者,根据 sKlotho 中位数水平进行分层。对患者进行不良结局(包括心血管(CV)发病率和全因死亡率)随访。

结果

在 36 个月的随访期间,75 名患者(51 例 CV 事件(包括 16 例 CV 死亡)和 40 例死亡)发生不良结局。根据 sKlotho 中位数水平分层后,sKlotho 水平较低的患者 CV 事件(38.2%比 19.5%, = 0.006)、全因死亡率(28.4%比 11.6%, = 0.003)和复合不良结局(51.0%比 24.2%, < 0.001)的风险更高。使用 Kaplan-Meier 生存曲线进行的分析也得到了类似的观察结果。Cox 回归分析表明,低 sKlotho 水平与 CV 发病率(1.942(1.030-3.661), = 0.040)、全因死亡率(2.073(1.023-4.203), = 0.043)和复合不良结局(1.818(1.092-3.026), = 0.021)在完全调整模型中均呈显著相关。

结论

sKlotho 水平是 MHD 患者不良结局(包括 CV 发病率和死亡率)的独立预测因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5271/7708020/2c93afa9444a/DM2020-4923970.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5271/7708020/3c030db04d06/DM2020-4923970.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5271/7708020/b0a522dcdc69/DM2020-4923970.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5271/7708020/2c93afa9444a/DM2020-4923970.003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5271/7708020/3c030db04d06/DM2020-4923970.001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5271/7708020/b0a522dcdc69/DM2020-4923970.002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5271/7708020/2c93afa9444a/DM2020-4923970.003.jpg

相似文献

1
Association of Soluble Klotho Level with Adverse Outcomes in Patients on Maintenance Hemodialysis.可溶性 Klotho 水平与维持性血液透析患者不良结局的关联。
Dis Markers. 2020 Nov 12;2020:4923970. doi: 10.1155/2020/4923970. eCollection 2020.
2
Relationship of Serum Soluble Klotho Levels and Echocardiographic Parameters in Patients on Maintenance Hemodialysis.维持性血液透析患者血清 Klotho 水平与超声心动图参数的关系。
Kidney Blood Press Res. 2019;44(3):396-404. doi: 10.1159/000499200. Epub 2019 May 10.
3
Fibroblast Growth Factor 23 and α-Klotho Protein Are Associated with Adverse Clinical Outcomes in Non-Dialysis CKD Patients.成纤维细胞生长因子 23 和 α-klotho 蛋白与非透析 CKD 患者的不良临床结局相关。
Kidney Blood Press Res. 2020;45(6):900-915. doi: 10.1159/000510351. Epub 2020 Oct 9.
4
Fibroblast growth factor-23 (FGF-23) / soluble Klotho protein (sKlotho) / sclerostin glycoprotein ratio disturbance is a novel risk factor for cardiovascular complications in ESRD patients receiving treatment with regular hemodialysis or hemodiafiltration.成纤维细胞生长因子-23(FGF-23)/可溶性klotho蛋白(sKlotho)/骨硬化蛋白糖蛋白比值紊乱是接受常规血液透析或血液滤过治疗的终末期肾病(ESRD)患者发生心血管并发症的一个新的危险因素。
Ter Arkh. 2018 Jun 20;90(6):48-54. doi: 10.26442/terarkh201890648-54.
5
Circulating α-Klotho Levels in Hemodialysis Patients and Their Relationship to Atherosclerosis.血液透析患者循环中α-klotho水平及其与动脉粥样硬化的关系。
Kidney Blood Press Res. 2018;43(4):1174-1182. doi: 10.1159/000492245. Epub 2018 Jul 31.
6
Pulmonary hypertension as an independent predictor of cardiovascular mortality and events in hemodialysis patients.肺动脉高压作为血液透析患者心血管死亡率和事件的独立预测因子。
Int Urol Nephrol. 2014 Jan;46(1):141-9. doi: 10.1007/s11255-013-0486-z. Epub 2013 Jun 21.
7
Associations of FGF-23 and sKlotho with cardiovascular outcomes among patients with CKD stages 2-4.成纤维细胞生长因子 23 和 Klotho 与 CKD 2-4 期患者心血管结局的关系。
Clin J Am Soc Nephrol. 2014 Jun 6;9(6):1049-58. doi: 10.2215/CJN.07870713. Epub 2014 Mar 27.
8
The prognostic value of soluble Klotho in patients with haemodialysis: a systematic review and meta-analysis.可溶性klotho对血液透析患者的预后价值:一项系统评价和荟萃分析。
Ther Adv Chronic Dis. 2020 Jul 30;11:2040622320940176. doi: 10.1177/2040622320940176. eCollection 2020.
9
Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis.维持性血液透析患者血清可溶性klotho蛋白与冠状动脉钙化及预后的关系
Iran J Public Health. 2018 Apr;47(4):510-518.
10
Soluble Klotho is not independently associated with cardiovascular disease in a population of dialysis patients.在透析患者群体中,可溶性klotho与心血管疾病并无独立关联。
BMC Nephrol. 2014 Dec 11;15:197. doi: 10.1186/1471-2369-15-197.

引用本文的文献

1
Serum Klotho Is Elevated in Patients with Acute Myocardial Infarction and Could Predict Poor In-Hospital Prognosis.急性心肌梗死患者血清klotho水平升高,且可预测住院期间预后不良。
J Cardiovasc Dev Dis. 2024 Sep 20;11(9):292. doi: 10.3390/jcdd11090292.
2
The association between klotho and kidney and cardiovascular outcomes: a comprehensive systematic review and meta-analysis.klotho与肾脏及心血管结局之间的关联:一项全面的系统评价和荟萃分析。
Clin Kidney J. 2024 Aug 23;17(9):sfae255. doi: 10.1093/ckj/sfae255. eCollection 2024 Sep.
3
Association between soluble α-klotho and mortality risk in middle-aged and older adults.

本文引用的文献

1
Secreted klotho from exosomes alleviates inflammation and apoptosis in acute pancreatitis.外泌体分泌的α-klotho可减轻急性胰腺炎中的炎症和细胞凋亡。
Am J Transl Res. 2019 Jun 15;11(6):3375-3383. eCollection 2019.
2
The Prognostic Role of Klotho in Patients with Chronic Kidney Disease: A Systematic Review and Meta-analysis.Klotho 在慢性肾脏病患者中的预后作用:系统评价和荟萃分析。
Dis Markers. 2019 Jun 2;2019:6468729. doi: 10.1155/2019/6468729. eCollection 2019.
3
Physical performance, plasma S-klotho, and all-cause mortality in elderly dialysis patients: A prospective cohort study.
可溶性 α-klotho 与中老年人群死亡风险的相关性。
Front Endocrinol (Lausanne). 2023 Aug 24;14:1246590. doi: 10.3389/fendo.2023.1246590. eCollection 2023.
4
A prospective study of the association between serum klotho and mortality among adults with rheumatoid arthritis in the USA.美国一项前瞻性研究成人类风湿关节炎患者血清 klotho 与死亡率的关系。
Arthritis Res Ther. 2023 Aug 16;25(1):149. doi: 10.1186/s13075-023-03137-0.
5
The controversy of klotho as a potential biomarker in chronic kidney disease.klotho作为慢性肾脏病潜在生物标志物的争议。
Front Pharmacol. 2022 Sep 21;13:931746. doi: 10.3389/fphar.2022.931746. eCollection 2022.
6
Non-coding RNAs associated with autophagy and their regulatory role in cancer therapeutics.非编码 RNA 与自噬的关系及其在癌症治疗中的调控作用。
Mol Biol Rep. 2022 Jul;49(7):7025-7037. doi: 10.1007/s11033-022-07517-8. Epub 2022 May 10.
7
Correlation Between Soluble Klotho and Vascular Calcification in Chronic Kidney Disease: A Meta-Analysis and Systematic Review.慢性肾脏病中可溶性klotho与血管钙化的相关性:一项Meta分析和系统评价
Front Physiol. 2021 Aug 13;12:711904. doi: 10.3389/fphys.2021.711904. eCollection 2021.
老年透析患者的体能、血浆 S-klotho 与全因死亡率:一项前瞻性队列研究。
Exp Gerontol. 2019 Jul 15;122:123-128. doi: 10.1016/j.exger.2019.05.003. Epub 2019 May 8.
4
Elevated Inflammatory Status and Increased Risk of Chronic Disease in Chronological Aging: Inflamm-aging or ?自然衰老过程中炎症状态升高与慢性病风险增加:炎症衰老还是其他?
Aging Dis. 2019 Feb 1;10(1):147-156. doi: 10.14336/AD.2018.0326. eCollection 2019 Feb.
5
The Klotho proteins in health and disease.Klotho 蛋白与健康和疾病。
Nat Rev Nephrol. 2019 Jan;15(1):27-44. doi: 10.1038/s41581-018-0078-3.
6
The role of klotho in chronic kidney disease.Klotho 在慢性肾脏病中的作用。
BMC Nephrol. 2018 Oct 22;19(1):285. doi: 10.1186/s12882-018-1094-z.
7
Oxidative Stress in Disease and Aging: Mechanisms and Therapies 2018.《疾病与衰老中的氧化应激:机制与疗法》2018年版
Oxid Med Cell Longev. 2018 Sep 23;2018:2835189. doi: 10.1155/2018/2835189. eCollection 2018.
8
Abdominal aortic calcification can predict all-cause mortality and CV events in dialysis patients: A systematic review and meta-analysis.腹主动脉钙化可预测透析患者的全因死亡率和心血管事件:系统评价和荟萃分析。
PLoS One. 2018 Sep 21;13(9):e0204526. doi: 10.1371/journal.pone.0204526. eCollection 2018.
9
Correlation between Soluble -Klotho and Renal Function in Patients with Chronic Kidney Disease: A Review and Meta-Analysis.可溶性 Klotho 与慢性肾脏病患者肾功能的相关性:综述与荟萃分析。
Biomed Res Int. 2018 Aug 12;2018:9481475. doi: 10.1155/2018/9481475. eCollection 2018.
10
Relationship between Serum Soluble Klotho Protein and Coronary Artery Calcification and Prognosis in Patients on Maintenance Hemodialysis.维持性血液透析患者血清可溶性klotho蛋白与冠状动脉钙化及预后的关系
Iran J Public Health. 2018 Apr;47(4):510-518.